Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, September 22, 2021
IBX, a global leader in biobanking, bioprocessing and analytics, has acquired UK based biospecimen storage specialists Roylance Pharma.
read more
WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading pharmaceutical, biotechnology, and medical device R&D services company with operations in China and the United States, today announced that its manufacturing subsidiary, Syn-The-All Pharmaceutical ...
read more
Metabolon now offers more than 150 qualified and/or validated targeted biochemical assays for pharmaceutical and biotechnology R&D.
read more
Thursday, January 08, 2026
Rentschler Biopharma and VarmX announced a collaboration to manufacture VarmX’s lead program, VMX-C001, for Phase 3 development and potential commercialization. VMX-C001 is a novel treatment to restore blood coagulation in patients requiring urgent ...
read more
SGS, a bio/pharmaceutical analytical and bioanalytical contract solutions provider, has announced that it has fully installed and validated an Immune Response Module (IRM) as part of its Watson laboratory information management system (LIMS), at its ...
read more
AveXis has signed an agreement to purchase an advanced biologics therapy manufacturing campus in Colorado, further expanding its capacity as it prepares to launch Zolgensma®.
read more
Proteon Therapeutics announced a long-term contract extension with Lonza Pharma & Biotech for the commercial supply of investigational vonapanitase’s active pharmaceutical ingredient.
read more
Catalent and Paragon Bioservices announced they have entered into a definitive agreement under which Catalent will acquire Paragon for $1.2 billion.
read more
Andelyn Biosciences announced a partnership with Evolyra Therapeutics to manufacture clinical-grade AAV gene therapies for treating types 2C and 2D Limb-Girdle Muscular Dystrophies (LGMDs).
read more
Thursday, October 20, 2022
Catalent announced a $12 million expansion program to increase biologics CGMP analytical capabilities at its flagship facility in Kansas City, Missouri.
read more
TurboFil Packaging Machines LLC is collaborating with Bridgewater, NJ-based Amneal Pharmaceuticals to develop an advanced automated assembly and vial filling machine for unidose liquid nasal devices.
read more
Agno Pharma, a CDMO specializing in small-molecule active pharmaceutical ingredients (APIs) and critical GMP intermediates announced the acquisition of Actylis Eugene, the legacy Cascade Chemistry business based in Eugene, Oregon.
read more
The Siemens technology group and Sartorius Stedim Biotech (SSB), a leading international supplier for the biopharmaceutical industry, have agreed on long-term cooperation in the area of automation. This agreement provides that Sartorius Stedim ...
read more
Wednesday, October 30, 2019
PPD has launched SiteCoach, providing advanced clinical research training, coaching and support to physicians, hospitals and academic institutions that are new to clinical research.
read more
Laureate Biopharma is pleased to announce its successful collaboration with Dyax Corp. for process development and cGMP production of a new treatment candidate for hereditary angioedema (HAE). The drug candidate, known as DX-2930, is a fully human ...
read more